| Name | Title | Contact Details |
|---|---|---|
Jeff Keating |
Chief Technology Officer | Profile |
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Nars Cosmetics, Inc, division of Shiseido Cosmetics America Ltd. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Nars Cosmetics, Inc, division of Shiseido Cosmetics America Ltd., please visit www.narscosmetics.com
Well and Company™ is igniting a self care revolution, offering its community members a powerful opportunity to share daily strategies that confront significant health and lifestyle challenges including aging, weight gain, fatigue, sleeplessness, stress, and loneliness. We “Embrace the Day™,” through social selling with our engaging content, innovative products and inspired community.
Axiom is a Yardley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rovin Med, is a Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.